Cargando…

Calcifediol: Why, When, How Much?

Vitamin D deficiency is a constantly growing health problem worldwide. Adults affected with hypovitaminosis D could experience negative consequences on their musculoskeletal system and extra-skeletal health. In fact, an optimal vitamin D status is essential to ensure the correct bone, calcium, and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Donati, Simone, Marini, Francesca, Giusti, Francesca, Palmini, Gaia, Aurilia, Cinzia, Falsetti, Irene, Iantomasi, Teresa, Brandi, Maria Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222038/
https://www.ncbi.nlm.nih.gov/pubmed/37242420
http://dx.doi.org/10.3390/ph16050637
_version_ 1785049600525074432
author Donati, Simone
Marini, Francesca
Giusti, Francesca
Palmini, Gaia
Aurilia, Cinzia
Falsetti, Irene
Iantomasi, Teresa
Brandi, Maria Luisa
author_facet Donati, Simone
Marini, Francesca
Giusti, Francesca
Palmini, Gaia
Aurilia, Cinzia
Falsetti, Irene
Iantomasi, Teresa
Brandi, Maria Luisa
author_sort Donati, Simone
collection PubMed
description Vitamin D deficiency is a constantly growing health problem worldwide. Adults affected with hypovitaminosis D could experience negative consequences on their musculoskeletal system and extra-skeletal health. In fact, an optimal vitamin D status is essential to ensure the correct bone, calcium, and phosphate homeostasis. To improve vitamin D status, it is important to not only increase the intake of food fortified with vitamin D, but also to administer vitamin D supplementation when required. Vitamin D3 (cholecalciferol) is the most widely used supplement. In recent years, the administration of calcifediol (25(OH)D3), the direct precursor of the biologically active form of vitamin D3, as oral vitamin D supplementation has progressively grown. Here, we report the potential medical benefits of some peculiar biological actions of calcifediol, discussing the possible specific clinical scenarios in which the oral intake of calcifediol could be most effective to restore the correct serum levels of 25(OH)D3. In summary, the aim of this review is to provide insights into calcifediol-related rapid non-genomic responses and the possible use of this vitamin D metabolite as a supplement for the treatment of people with a higher risk of hypovitaminosis D.
format Online
Article
Text
id pubmed-10222038
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102220382023-05-28 Calcifediol: Why, When, How Much? Donati, Simone Marini, Francesca Giusti, Francesca Palmini, Gaia Aurilia, Cinzia Falsetti, Irene Iantomasi, Teresa Brandi, Maria Luisa Pharmaceuticals (Basel) Review Vitamin D deficiency is a constantly growing health problem worldwide. Adults affected with hypovitaminosis D could experience negative consequences on their musculoskeletal system and extra-skeletal health. In fact, an optimal vitamin D status is essential to ensure the correct bone, calcium, and phosphate homeostasis. To improve vitamin D status, it is important to not only increase the intake of food fortified with vitamin D, but also to administer vitamin D supplementation when required. Vitamin D3 (cholecalciferol) is the most widely used supplement. In recent years, the administration of calcifediol (25(OH)D3), the direct precursor of the biologically active form of vitamin D3, as oral vitamin D supplementation has progressively grown. Here, we report the potential medical benefits of some peculiar biological actions of calcifediol, discussing the possible specific clinical scenarios in which the oral intake of calcifediol could be most effective to restore the correct serum levels of 25(OH)D3. In summary, the aim of this review is to provide insights into calcifediol-related rapid non-genomic responses and the possible use of this vitamin D metabolite as a supplement for the treatment of people with a higher risk of hypovitaminosis D. MDPI 2023-04-22 /pmc/articles/PMC10222038/ /pubmed/37242420 http://dx.doi.org/10.3390/ph16050637 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Donati, Simone
Marini, Francesca
Giusti, Francesca
Palmini, Gaia
Aurilia, Cinzia
Falsetti, Irene
Iantomasi, Teresa
Brandi, Maria Luisa
Calcifediol: Why, When, How Much?
title Calcifediol: Why, When, How Much?
title_full Calcifediol: Why, When, How Much?
title_fullStr Calcifediol: Why, When, How Much?
title_full_unstemmed Calcifediol: Why, When, How Much?
title_short Calcifediol: Why, When, How Much?
title_sort calcifediol: why, when, how much?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222038/
https://www.ncbi.nlm.nih.gov/pubmed/37242420
http://dx.doi.org/10.3390/ph16050637
work_keys_str_mv AT donatisimone calcifediolwhywhenhowmuch
AT marinifrancesca calcifediolwhywhenhowmuch
AT giustifrancesca calcifediolwhywhenhowmuch
AT palminigaia calcifediolwhywhenhowmuch
AT auriliacinzia calcifediolwhywhenhowmuch
AT falsettiirene calcifediolwhywhenhowmuch
AT iantomasiteresa calcifediolwhywhenhowmuch
AT brandimarialuisa calcifediolwhywhenhowmuch